Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (688336) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Why is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ?

The company has declared Positive results for the last 10 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 2,979.1 MM
ROCE(HY) Highest at 15.87%
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost

With ROE of 12.41%, it has a fair valuation with a 6.06 Price to Book Value

Over the past year, while the stock has generated a return of 110.19%, its profits have risen by 131.7%
At the current price, the company has a high dividend yield of 0.2

Market Beating Performance

The stock has generated a return of 110.19% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

19.07%

2.11

74.40%

China Shanghai Composite

23.91%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

41.68%

EBIT Growth (5y)

74.60%

EBIT to Interest (avg)

22.12

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.28

Tax Ratio

4.65%

Dividend Payout Ratio

10.28%

Pledged Shares

Institutional Holding

ROCE (avg)

2.47%

ROE (avg)

3.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.83

EV to EBIT

9.83

EV to EBITDA

9.55

EV to Capital Employed

4.41

EV to Sales

7.30

PEG Ratio

0.03

Dividend Yield

0.23%

ROCE (Latest)

44.87%

ROE (Latest)

33.75%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

34What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 2,998.09 MM

ROCE(HY)

Highest at 41.63%

RAW MATERIAL COST(Y)

Fallen by -11.03% (YoY

CASH AND EQV(HY)

Highest at CNY 7,229.23 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 17.79 times

NET SALES(Q)

At CNY 431.23 MM has Grown at 39.62%

PRE-TAX PROFIT(Q)

At CNY 167.77 MM has Grown at 55.97%

NET PROFIT(Q)

At CNY 156.64 MM has Grown at 65.61%

-1What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -17.11 %

Here's what is working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Operating Cash Flow

Highest at CNY 2,998.09 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 431.23 MM has Grown at 39.62%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 167.77 MM has Grown at 55.97%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 156.64 MM has Grown at 65.61%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 7,229.23 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 17.79 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -11.03% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Debt-Equity Ratio

Highest at -17.11 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio